Second-line lenvatinib in patients with recurrent endometrial cancer.
暂无分享，去创建一个
I. Vergote | D. Miller | Y. Funahashi | M. Powell | R. Penson | M. Ren | M. Bidziński | C. Dutcus | Agustin A. Garcia | M. Teneriello | T. Kadowaki | C. Cebotaru | O. Mikheeva | D. Miller